Manuel Mendizabal

25PUBLICATIONS
93CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMedical molecular engineering of nucleic acids and proteinsPrimary health careRadiology and organ imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Apr 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis.

Federico Piñero, Margarita Anders, Carla Bermudez

|Apr 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.

Winston Dunn, Yanming Li, Ashwani K Singal

|Nov 23, 2022
Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.

Fernando Bessone, Antonella Ferrari, Nelia Hernandez

|Oct 05, 2022
Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.

Manuel Mendizabal, Marcos Thompson, Esteban Gonzalez-Ballerga

|Jul 29, 2022
Heterologous adenovirus-vector/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipients.

Manuel Mendizabal, Nicolás Ducasa, Paula Benencio

|May 14, 2022
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.

Cumali Efe, Anand V Kulkarni, Benedetta Terziroli Beretta-Piccoli

Pageof 5

Frequent Collaborators

11 joint publications

Ezequiel Ridruejo

6 joint publications

Federico Piñero

3 joint publications

Marcelo Silva

3 joint publications

Sebastian Marciano